IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER

被引:10
作者
Aguloglu, Nursin [1 ]
Aksu, Aysegul [1 ]
Akyol, Murat [1 ]
Katgi, Nuran [1 ]
Doksoz, Tugce Ciftci [1 ]
机构
[1] Bahcesehir Cam & Sakura Hastanesi, Istanbul, Turkey
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2022年 / 61卷 / 06期
关键词
18F-FDG-PET; CT; Lung cancer; Textural analysis; EGFR; ALK; IMAGING PHENOTYPES; SOMATIC MUTATIONS; ADENOCARCINOMA;
D O I
10.1055/a-1868-4918
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Identification of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) mutation types is of great importance before treatment with tyrosine kinase inhibitors (TKIs). Radiomics is a new strategy for noninvasively predicting the genetic status of cancer. We aimed to evaluate the predictive power of 18F-FDG PET/CT-based radiomic features for mutational status before treatment in non-small cell lung cancer (NSCLC) and to develop a predictive model based on radiomic features. Methods Images of patients who underwent 18F-FDG PET/CT for initial staging with the diagnosis of NSCLC between January 2015 and July 2020 were evaluated using LIFEx software. The region of interest (ROI) of the primary tumor was established and volumetric and textural features were obtained. Clinical data and radiomic data were evaluated with machine learning (ML) algorithms to create a model. Results For EGFR mutation prediction, the most successful machine learning algorithm obtained with GLZLM_GLNU and clinical data was Naive Bayes (AUC: 0.751, MCC: 0.347, acc: 71.4%). For ALK rearrangement prediction, the most successful machine learning algorithm obtained with GLCM_correlation, GLZLM_LZHGE and clinical data was evaluated as Naive Bayes (AUC: 0.682, MCC: 0.221, acc: 77.4%). Conclusions In our study, we created prediction models based on radiomic analysis of 18F-FDG PET/CT images. Tissue analysis with ML algorithms are non-invasive methods for predicting ALK rearrangement and EGFR mutation status in NSCLC, which may be useful for targeted therapy selection in a clinical setting.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 50 条
[31]   18F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer [J].
Wang, Jie ;
Zheng, Zhonghang ;
Zhang, Yi ;
Tan, Weiyue ;
Li, Jing ;
Xing, Ligang ;
Sun, Xiaorong .
FRONTIERS IN ONCOLOGY, 2023, 13
[32]   Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer [J].
Pellegrino, Sara ;
Fonti, Rosa ;
Mazziotti, Emanuela ;
Piccin, Luisa ;
Mozzillo, Eleonora ;
Iano, Vincenzo Dam ;
Matano, Elide ;
De Placido, Sabino ;
Del Vecchi, Silvana .
ANNALS OF NUCLEAR MEDICINE, 2019, 33 (12) :937-944
[33]   Non-invasively Discriminating the Pathological Subtypes of Non-small Cell Lung Cancer with Pretreatment 18F-FDG PET/CT Using Deep Learning [J].
Zhao, Hongyue ;
Su, Yexin ;
Lyu, Zhehao ;
Tian, Lin ;
Xu, Peng ;
Lin, Lin ;
Han, Wei ;
Fu, Peng .
ACADEMIC RADIOLOGY, 2024, 31 (01) :35-45
[34]   Are Pretreatment 18F-FDG PET Tumor Textural Features in Non-Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy? [J].
Cook, Gary J. R. ;
Yip, Connie ;
Siddique, Muhammad ;
Goh, Vicky ;
Chicklore, Sugama ;
Roy, Arunabha ;
Marsden, Paul ;
Ahmad, Shahreen ;
Landau, David .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (01) :19-26
[35]   EGFR Mutation Prediction Using F18-FDG PET-CT Based Radiomics Features in Non-small Cell Lung Cancer [J].
Henriquez, H. ;
Fuentes, D. ;
Suarez, F. ;
Gonzalez, P. .
INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS 2022, ICBHI 2022, 2024, 108 :24-34
[36]   CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer [J].
Agazzi, Giorgio Maria ;
Ravanelli, Marco ;
Roca, Elisa ;
Medicina, Daniela ;
Balzarini, Piera ;
Pessina, Carlotta ;
Vermi, William ;
Berruti, Alfredo ;
Maroldi, Roberto ;
Farina, Davide .
RADIOLOGIA MEDICA, 2021, 126 (06) :786-794
[37]   Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics [J].
Minamimoto, Ryogo ;
Jamali, Mehran ;
Gevaert, Olivier ;
Echegaray, Sebastian ;
Khuong, Amanda ;
Hoang, Chuong D. ;
Shrager, Joseph B. ;
Plevritis, Sylvia K. ;
Rubin, Daniel L. ;
Leung, Ann N. ;
Napel, Sandy ;
Quon, Andrew .
ONCOTARGET, 2017, 8 (32) :52792-52801
[38]   The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer [J].
Lee, Jeong Won ;
Kim, Eun Young ;
Kim, Dae Joon ;
Lee, Jae-Hoon ;
Kang, Won Jun ;
Lee, Jong Doo ;
Yun, Mijin .
EUROPEAN RADIOLOGY, 2016, 26 (12) :4515-4523
[39]   The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer [J].
Liu, Ao ;
Han, Anqin ;
Zhu, Hui ;
Ma, Li ;
Huang, Yong ;
Li, Minghuan ;
Jin, Feng ;
Yang, Qiuan ;
Yu, Jinming .
ONCOTARGET, 2017, 8 (20) :33736-33744
[40]   The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer [J].
Jeong Won Lee ;
Eun Young Kim ;
Dae Joon Kim ;
Jae-Hoon Lee ;
Won Jun Kang ;
Jong Doo Lee ;
Mijin Yun .
European Radiology, 2016, 26 :4515-4523